No picture, placeholder image
No picture, placeholder image
Professor Department of Clinical Medicine carsten.nieder@uit.no

Carsten Nieder



  • Carsten Nieder, Luka Stanisavljevic, Bård Mannsåker :
    Comprehensive Analysis of Blood Test Results Predicting Prognosis in Patients Undergoing Whole-brain Radiotherapy for Brain Metastases
    Anticancer Research 2024 DOI
  • Carsten Nieder, Ellinor Christin Haukland, Bård Mannsåker :
    Return to Work After Breast Cancer Treatment: An Electronic Health Record-based Study in North Norway
    Anticancer Research 2024 DOI
  • Carsten Nieder, Luka Stanisavljevic, Astrid Dalhaug, Ellinor Christin Haukland :
    Survival after docetaxel for metastatic castration-resistant prostate cancer in a rural health care setting
    Wspólczesna Onkologia 2024 ARKIV / DOI
  • Carsten Nieder, Silje Kristine Johnsen, Annette M. Winther, Bård Mannsåker :
    Patient-reported symptoms before adjuvant locoregional radiotherapy for breast cancer: triple-negative histology impacts the symptom burden
    Strahlentherapie und Onkologie (Print) 2024 ARKIV / DOI
  • Carsten Nieder, Siv Gyda Aanes, Astrid Dalhaug, Ellinor Christin Haukland :
    Sex Differences in Presentation, Treatment, and Survival in Patients Receiving Palliative (Chemo)Radiotherapy for Non-Small Cell Lung Cancer
    Anticancer Research 2024 DOI
  • Carsten Nieder, Luka Stanisavljevic, Ellinor Christin Haukland :
    Factors Associated With Prescription of Systemic Therapy in Real-world Patients With Metastatic Renal Cell Cancer Managed in a Rural Region
    Cancer Diagnosis & Prognosis (CDP) 2024 ARKIV / DOI
  • Carsten Nieder, Stine M. Jensen, Solveig Nilsen, Ellinor Christin Haukland :
    Palliative Radiation Treatment in Patients Managed With Advanced/Interventional Pain Therapy such as Pump-delivered Continuous Opioids
    Anticancer Research 2024 DOI
  • Carsten Nieder, Siv Gyda Aanes, Luka Stanisavljevic, Bård Mannsåker, Ellinor Christin Haukland :
    Return to work in younger patients with brain metastases who survived for 2 years or more
    Journal of Neuro-Oncology 2024 ARKIV / DOI
  • Carsten Nieder, Ellinor Christin Haukland, Luka Stanisavljevic, Bård Mannsåker :
    Stereotactic radiotherapy for patients with bone metastases: a selected group with low rate of radiation treatment during the last month of life?
    Radiation Oncology 2024 ARKIV / DOI
  • Carsten Nieder, Siv Gyda Aanes, Ellinor Christin Haukland :
    Days at home in the last three months of life: patterns-of-care analysis in patients with non-small cell lung cancer
    Wspólczesna Onkologia 2023 ARKIV / DOI
  • Carsten Nieder, Luka Stanisavljevic, Bård Mannsåker, Ellinor Christin Haukland :
    Independent validation of a risk stratification model predicting survival in elderly patients irradiated for bone metastases
    Anticancer Research 2023 ARKIV / DOI
  • Carsten Nieder, Astrid Dalhaug :
    Prognostic factors and independent validation of a risk stratification model in octogenarian patients irradiated for brain metastases
    Anticancer Research 2023 ARKIV / DOI
  • Carsten Nieder, Nicolaus H. Andratschke, Anca L. Grosu :
    Brain Metastases: Is There Still a Role for Whole-Brain Radiation Therapy?
    Seminars in Radiation Oncology 2023 ARKIV / DOI
  • Carsten Nieder, Luka Stanisavljevic, Bård Mannsåker, Ellinor Christin Haukland :
    Independent Validation of a Unifying Prognostic Model for Intracranial and Extracranial Metastasis-directed Radiotherapy
    Anticancer Research 2023 ARKIV / DOI
  • Carsten Nieder, Nicolaus H. Andratschke, Anca L. Grosu :
    Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
    Frontiers in Oncology 2023 ARKIV / DOI
  • Carsten Nieder, Kristian Steinsvik Imingen :
    Palliative Radiotherapy for Non-metastatic Non-small-cell Lung Cancer: Impact of Blood Test Results on Survival
    In Vivo 2023 ARKIV / DOI
  • Carsten Nieder, Ellinor Christin Haukland, Bård Mannsåker, Astrid Dalhaug :
    Palliative appropriateness criteria: external validation of a new method to evaluate the suitability of palliative radiotherapy fractionation
    Strahlentherapie und Onkologie (Print) 2023 ARKIV / DOI
  • Carsten Nieder, Bård Mannsåker, Astrid Dalhaug :
    Percent of remaining life on palliative radiation treatment: solely a function of fractionation?
    Reports of Practical Oncology and Radiotherapy 2023 ARKIV / DOI
  • Carsten Nieder, Bård Mannsåker, Luka Stanisavljevic, Ellinor Christin Haukland :
    Patterns of Care and Survival in Cancer Patients with Brain Metastases Receiving Immune Checkpoint Inhibitors
    Oncology Research and Treatment 2023 ARKIV / DOI
  • Carsten Nieder, Luka Stanisavljevic, Bård Mannsåker, Ellinor Christin Haukland :
    Early death after palliative radiation treatment: 30-, 35- and 40-day mortality data and statistically robust predictors
    Radiation Oncology 2023 ARKIV / DOI
  • Carsten Nieder, Ellinor Christin Haukland, Bård Mannsåker, Astrid Dalhaug :
    The LabPS score: Inexpensive, Fast, and Site-agnostic Survival Prediction
    American Journal of Clinical Oncology 2023 ARKIV / DOI
  • Ilinca Popp, Nanna E. Hartong, Carsten Nieder, Anca-L. Grosu :
    PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?
    Cancers 2023 ARKIV / DOI
  • Carsten Nieder, Nicolaus H. Andratschke, Anca L. Grosu :
    How we treat octogenarians with brain metastases
    Frontiers in Oncology 2023 ARKIV / DOI
  • Carsten Nieder, David McKenzie Grant :
    Considerations regarding carotid artery dose in radiotherapy of the cervical spine
    Clinical and Translational Radiation Oncology 2023 ARKIV / DOI
  • Carsten Nieder, Jonas Willmann, Nicolaus H. Andratschke :
    Prospective randomized clinical studies involving reirradiation: update of a systematic review
    Strahlentherapie und Onkologie (Print) 2023 ARKIV / DOI
  • Jonas Willmann, L. Appelt, Panagiotis Balermpas, G. Baumert, Dirk de Ruysscher, Morten Hoyer et al.:
    Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform
    Radiotherapy and Oncology 2023 ARKIV / DOI
  • Carsten Nieder, Siv Gyda Aanes, Ellinor Christin Haukland :
    Primary systemic therapy for patients with brain metastases from lung cancer ineligible for targeted agents
    Journal of Cancer Research and Clinical Oncology 2022 ARKIV / DOI
  • Nicolaus Andratschke, Jonas Willmann, Ane L Appelt, Najlaa Alyamani, Panagiotis Balermpas, Brigitta G Baumert et al.:
    European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making
    The Lancet Oncology 2022 ARKIV / DOI
  • Carsten Nieder, Siv Gyda Aanes, Ellinor Christin Haukland :
    Palliative non-small cell lung cancer treatment and end-of-life care stratified by sex and childlessness: an important interplay in unmarried patients?
    Supportive Care in Cancer 2022 ARKIV / DOI
  • Carsten Nieder, Bård Mannsåker, Rosalba Yobuta :
    Independent External Validation of the METSSS Model Predicting Survival after Palliative Radiotherapy
    Anticancer Research 2022 ARKIV / DOI
  • Carsten Nieder, Astrid Dalhaug, Bård Mannsåker :
    Established Serum Biomarkers Are Prognostic Factors in Patients With Oligometastatic Cancer and Brain Involvement
    In Vivo 2022 DOI
  • Carsten Nieder, Joakim Grønning Ressheim, Ellinor Christin Haukland, Bård Mannsåker :
    Implementation of Locoregional Adjuvant Radiotherapy for Breast Cancer in a Rural Healthcare Region: Toxicity Outcomes in the Initial Cohort
    Anticancer Research 2022 ARKIV / DOI
  • Carsten Nieder, Ilinca Popp, Mandy Hintz, Anca Ligia Grosu :
    External Validation of the Graded Prognostic Assessment in Patients with Brain Metastases from Small Cell Lung Cancer
    Current Oncology 2022 ARKIV / DOI
  • Carsten Nieder, Siv Gyda Aanes, Ellinor Christin Haukland :
    Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer
    Anticancer Research 2022 ARKIV / DOI
  • Carsten Nieder, Luka Stanisavljevic, Siv Gyda Aanes, Bård Mannsåker, Ellinor Christin Haukland :
    30-day mortality in patients treated for brain metastases: extracranial causes dominate
    Radiation Oncology 2022 ARKIV / DOI
  • Carsten Nieder, Ellinor Christin Haukland, Bård Mannsåker :
    Shortened Palliative Radiotherapy Results in a Lower Rate of Treatment During the Last Month of Life
    Cureus - Journal of Medical Science 2022 ARKIV / DOI
  • Carsten Nieder, Nicolaus H. Andratschke, Anca L. Grosu :
    Personalized treatment of brain metastases: Evolving survival prediction models may benefit from evaluation of serum tumor markers (narrative review)
    Frontiers in Oncology 2022 ARKIV / DOI
  • Carsten Nieder, Luka Stanisavljevic :
    Independent Validation of a Risk Stratification Model Predicting Survival in Patients With Metastatic Hormone-sensitive Prostate Cancer
    Anticancer Research 2022 ARKIV / DOI
  • Carsten Nieder, Luka Stanisavljevic, Astrid Dalhaug, Ellinor Christin Haukland :
    Feasibility and efficacy of early docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in a rural health care setting
    Scandinavian Journal of Urology 2022 ARKIV / DOI
  • Carsten Nieder, Bård Mannsåker, Rosalba Yobuta :
    Independent validation of a comprehensive machine learning approach predicting survival after radiotherapy for bone metastases
    Anticancer Research 2021 DOI
  • Carsten Nieder, Bård Mannsåker, Rosalba Yobuta :
    Validation of a graded prognostic model in patients with brain metastases treated with whole-brain radiotherapy instead of radiosurgery
    In Vivo 2021 ARKIV / DOI
  • Hiroshi Doi, Keisuke Tamari, Ryoong-Jin Oh, Carsten Nieder :
    New clinical data on human spinal cord re-irradiation tolerance
    Strahlentherapie und Onkologie (Print) 2021 ARKIV / DOI
  • Carsten Nieder, Kristian Steinsvik Imingen, Ellinor Christin Haukland :
    Palliative Thoracic Radiotherapy for Non-Small Cell Lung Cancer in Outpatients: Reasons for Unplanned Hospitalization and Its Impact on Survival
    Journal of Clinical Medicine Research 2021 DOI
  • Carsten Nieder, Astrid Dalhaug, Ellinor Christin Haukland :
    Recursive partitioning analysis of systemic therapy after radiotherapy in patients with brain metastases
    Oncology Research and Treatment 2021 ARKIV / DOI
  • Carsten Nieder, Silje Kristine Johnsen, Anette Merethe Winther :
    Symptom Burden in Patients Treated With Palliative Radiotherapy Before and During the COVID-19 Pandemic
    Anticancer Research 2021 DOI
  • Carsten Nieder, Astrid Dalhaug, Ellinor Christin Haukland :
    The LabBM score is an excellent survival prediction tool in patients undergoing palliative radiotherapy
    Reports of Practical Oncology and Radiotherapy 2021 ARKIV / DOI
  • Siv Gyda Aanes, Ellinor Christin Haukland, Siri Wiig, Carsten Nieder, David Westfall Bates :
    Research protocol Monitoring adverse events caused by systemic anticancer treatment – Safer Personalized Cancer Treatment digital follow-up - SPeCT HNF1626-22
    2024 ARKIV
  • Carsten Nieder :
    In Regard to Alcorn et al
    International Journal of Radiation Oncology, Biology, Physics 2021 DOI
  • Carsten Nieder, Anca-Ligia Grosu :
    Radiate Once More
    International Journal of Radiation Oncology, Biology, Physics 2021 DOI
  • Carsten Nieder, Kristian S. Imingen :
    An Institutional Audit of Maximum Heart Dose in Patients Treated With Palliative Radiotherapy for Non-small Cell Lung Cancer
    In Vivo 2021 DOI

  • The 50 latest publications is shown on this page. See all publications in Cristin here →